Thompson Coburn is pleased to announce that Dr. Elizabeth “Betsy” Haanes has joined the firm as a partner in our Washington, D.C., office. An accomplished scientist with a Ph.D. in microbiology, Dr. Haanes will practice in the firm’s Intellectual Property group. She previously served as a director at Sterne Kessler Goldstein & Fox.
Dr. Haanes advises innovator biotechnology and pharmaceutical companies on best practices for the worldwide protection of their intellectual property. In all aspects of her practice, she focuses on creating innovative, long-term legal strategies that integrate seamlessly into her clients' technological and business objectives.
An experienced legal counselor, Dr. Haanes advises clients on the creation and management of high-value patent portfolios, freedom-to-operate and patentability issues, validity and infringement issues, and due diligence investigations in connection with acquisitions and investments.
Her clients represent a diverse body of entities in technology areas such as vaccines, infectious diseases, medical diagnostics, biomarkers, personalized medicine, therapeutic antibodies, therapeutic nucleic acids, genomics, proteomics, and gene therapy.
Before practicing law, Dr. Haanes performed infectious disease and vaccine research in academia and industry. She published widely in the areas of microbial pathogenesis, molecular virology, and vaccines, and is an inventor on numerous patents and published applications relating to recombinant vaccines.
Dr. Haanes earned her law degree from the University of Colorado. She obtained her Ph.D. from the University of Minnesota and a B.S. in biology from the University of Michigan.
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.